PMID- 17978553
OWN - NLM
STAT- MEDLINE
DCOM- 20071228
LR  - 20190724
IS  - 0031-6903 (Print)
IS  - 0031-6903 (Linking)
VI  - 127
IP  - 11
DP  - 2007 Nov
TI  - [Need for pharmacists to contribute to infection control and building patient 
      safety].
PG  - 1789-95
AB  - With the revisions to the Japanese medical institutions law of April 2006, an 
      improved medical care security system in a medical institution is indispensable. 
      More and more medical institutions are now assigning full-time pharmacists to the 
      task of medical safety. Hospital pharmacy sections are utilizing a valid 
      evaluation system developed by the Japan Council for Quality Health Care. 
      Pharmaceutical specialists who contribute to medical security, such as certified 
      oncology pharmacists and certified infection control pharmacists (CICPha) are 
      much awaited. In addition, the DPC (Diagnosis Procedure Combination) system has 
      now become widespread in Japan, and the call is for pharmaceutical care that can 
      decrease medical costs. It is imperative for health care systems to assure the 
      appropriate use of drugs to decrease medical costs without reducing medical 
      services. CICPha can contribute to the antimicrobial management program, and has 
      also focused on medical care security. Several antimicrobial management programs 
      of broad-spectrum agents, i.e., formulary restriction and prior approval, are 
      gradually being enforced in Japan. The CICPha role is far-reaching, and it should 
      make a concerted effort to prevent the injudicious use of antimicrobial agents 
      resulting in the emergence of drug resistance; this must be handled by infection 
      control doctors and nurses along with microbiological technicians. The CICPha 
      must regulate the appropriate use of these agents, and perform surveillance of 
      antimicrobial use and resistance (AUR). We describe the necessity and evaluation 
      of AUR, and also underscore the necessity of training clinical pharmacists who 
      will contribute to patient safety in days to come.
FAU - Katayama, Toshiya
AU  - Katayama T
AD  - Department of Pharmacy, Yokkaichi Social Insurance Hospital, Yokkaichi City, 
      Japan. yokkab32@comet.ocn.ne.jp
LA  - jpn
PT  - English Abstract
PT  - Journal Article
PT  - Review
PL  - Japan
TA  - Yakugaku Zasshi
JT  - Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
JID - 0413613
RN  - 0 (Anti-Infective Agents)
SB  - IM
MH  - *Anti-Infective Agents/administration & dosage
MH  - Drug Resistance, Microbial
MH  - Education, Pharmacy/trends
MH  - Health Care Costs
MH  - Humans
MH  - *Infection Control
MH  - Japan
MH  - *Patients
MH  - *Pharmaceutical Services
MH  - *Pharmacists
MH  - *Professional Role
MH  - *Safety Management
RF  - 45
EDAT- 2007/11/06 09:00
MHDA- 2007/12/29 09:00
CRDT- 2007/11/06 09:00
PHST- 2007/11/06 09:00 [pubmed]
PHST- 2007/12/29 09:00 [medline]
PHST- 2007/11/06 09:00 [entrez]
AID - JST.JSTAGE/yakushi/127.1789 [pii]
AID - 10.1248/yakushi.127.1789 [doi]
PST - ppublish
SO  - Yakugaku Zasshi. 2007 Nov;127(11):1789-95. doi: 10.1248/yakushi.127.1789.